TRI group TFI group
Time from onset to reperfusion (h)    
  6.5±2.4 6.4±3.5
Access site crossover 15(4.41) 4(1.24)*
Number of narrowed coronary arteries
0 [n (%)]
1 [n (%)]
2 [n (%)]
3 [n (%)]

2(0.58)
173(50.88)
98(28.82)
67(19.7)

1(0.31)
161(50.15)
100(31.15)
59(18.38)
Pre-PCI TIMI flow
0 [n (%)]
1 [n (%)]
2 [n (%)]
3 [n (%)]
Post-PCI TIMI flow
0 [n (%)]
1 [n (%)]
2 [n (%)]
3 [n (%)]

284(83.52)
27(7.94)
18(5.29)
11(3.23)

2(0.58)
7(2.05)
23(6.76)
308(90.58)


277(86.29)
19(5.91)
15(4.67)
10(3.11)

2(0.69)
5(1.55)
20(6.23)
294(91.58)

IRA
LM[n (%)]
LAD[n (%)]
LCX[n (%)]
RCA[n (%)]

7(2.05)
178(52.35)
44(12.94)
113(33.23)

11(3.42)
171(53.27)
37(11.52)
106(33.02)
GP IIb/IIIa antagonist [n (%)] 254(74.7) 237(73.83)
Contrast dose(ml) 110±29 105±38
Devices used in PCI
Thrombus aspirator [n (%)]
IABP[n (%)]
Temporary pacemaker[n (%)]
Stent [n (%)]
DES [n (%)]

259(76.17
12(3.52)
22(6.47)
330(97.05)
309(90.88)

232(72.17)
17(5.29)
19(5.91)
316(98.44)
299(93.14)
Underwent secondary PCI of non-IRA[n (%)] 56(16.47) 48(14.95)
Values are presented as mean ± standard deviation or n (%).
*Denotes statistical difference (p < 0.05) compared to normal group.
TRI, transradial intervention; TFI, transfemoral intervention; PCI, percutaneous coronary intervention; IRA, infarction related artery; DES, drug eluting stent; IRA, infarction related artery; IABP, intraaortic balloon pump; LAD, left anterior descending; LCX, left circumflex; RCA, right coronary artery; GP, glucoprotein
Table 2: Coronary angiographic and percutaneous coronary interventional outcomes